Litcius/Paper detail

Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials

Gabriel Marinheiro, Julyana Medeiros Dantas, Antônio Mutarelli, Artur Menegaz de Almeida, Gabriel de Almeida Monteiro, Djinane Spinosa Zerlotto, João Paulo Mota Telles

2024Neurological Sciences17 citationsDOI

Topics & Concepts

MedicinePlaceboRandomized controlled trialAdverse effectInternal medicineClinical Global ImpressionMeta-analysisCochrane LibraryPsychomotor agitationIncidence (geometry)AnesthesiaAlternative medicineOpticsPhysicsPathologyDementia and Cognitive Impairment ResearchSchizophrenia research and treatmentHealthcare Decision-Making and Restraints
Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials | Litcius